Why isn’t gene therapy available to more patients? Blame millionaire prices and uncertainty as to its effectiveness
By Oriol Güell,
El País
| 07. 07. 2024
Image by Nick Youngson from Pix4free
Darius is 15 years old and is a dazzling example of how medical research has advanced. Born with a rare and lethal genetic disease, early active cerebral adrenoleukodystrophy — CALD, the same condition that killed his older brother Danuk — the adolescent boy is today, healthy and happy in his hometown of Quintanar de la Orden, in the Spanish province of Toledo. His recovery has been thanks to a gene therapy called Skysona. A benevolent virus, a Trojan horse that was introduced into his body when the boy was five years old, it was able to replace the boy’s defective gene with a healthy one, thus saving his life.
But to the frustration of his doctors and other families, Darius’s treatment has not been available on the European market since 2021, due to a decision made by its pharmaceutical company Bluebird Bio that has left dozens of young people in the EU without the opportunity to follow Darius down the same path to survival. “It is difficult to comprehend,” says Carmen Sever, president...
Related Articles
By Elizabeth Dwoskin and Zoeann Murphy, The Washington Post | 10.01.2025
MEXICO CITY — When she walked into an IVF clinic in June, Alin Quintana knew it would be the last time she would try to conceive a child. She had prepared herself spiritually and mentally for the visit: She had traveled to a nearby...
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Jessica Mouzo, El País | 10.03.2025
DNA is the molecule of life: this double-helix structure, present in every cell in the body and organized into fragments called genes, stores the instructions for making organisms function. It is a highly precise biological machine, but sometimes it breaks...
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...